Meta-Analysis on the Chinese Herbal Formula
Chinese herbal formula
Xiaoer-Feike granules
acute lower respiratory infection
meta-analysis
randomized controlled trials
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2020
2020
Historique:
received:
06
09
2019
accepted:
24
08
2020
entrez:
16
11
2020
pubmed:
17
11
2020
medline:
17
11
2020
Statut:
epublish
Résumé
Over the past five years the Chinese herbal formula (CHF) medicine, This study systematically identified randomized controlled trials (RCTs) of XFG treatments for ALRI through July 2019 using four English-databases (PubMed, Cochrane Library, Ovid, and Web of Science) and four Chinese-databases (Sino-med database, China National Knowledge Infrastructure (CNKI), VIP database, and the WANFANG database). We then performed a quality assessment and data analysis with Review Manager 5.3.5 and Stata 15.1. Twenty-one RCTs involving 3425 patients were randomly divided into an XFG group and a conventional medicine (CM) group. The results showed that the clinical efficacy rate (CER) of the XFG group was significantly higher than that of the CM group ( The findings of this meta-analysis support the use of XFG in the treatment of ALRI. However, these results should be treated with caution due to the significant heterogeneity and publication bias of existing data. Further well-designed and high-quality RCTs are needed to interrogate the efficacy and safety of XFG.
Sections du résumé
BACKGROUND
BACKGROUND
Over the past five years the Chinese herbal formula (CHF) medicine,
METHODS
METHODS
This study systematically identified randomized controlled trials (RCTs) of XFG treatments for ALRI through July 2019 using four English-databases (PubMed, Cochrane Library, Ovid, and Web of Science) and four Chinese-databases (Sino-med database, China National Knowledge Infrastructure (CNKI), VIP database, and the WANFANG database). We then performed a quality assessment and data analysis with Review Manager 5.3.5 and Stata 15.1.
RESULTS
RESULTS
Twenty-one RCTs involving 3425 patients were randomly divided into an XFG group and a conventional medicine (CM) group. The results showed that the clinical efficacy rate (CER) of the XFG group was significantly higher than that of the CM group (
CONCLUSIONS
CONCLUSIONS
The findings of this meta-analysis support the use of XFG in the treatment of ALRI. However, these results should be treated with caution due to the significant heterogeneity and publication bias of existing data. Further well-designed and high-quality RCTs are needed to interrogate the efficacy and safety of XFG.
Identifiants
pubmed: 33192498
doi: 10.3389/fphar.2020.496348
pmc: PMC7642815
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
496348Informations de copyright
Copyright © 2020 You, Li, Li, Yang, Chen, Chen and Liu.
Références
Evid Based Complement Alternat Med. 2015;2015:913461
pubmed: 25691910
Neurochem Res. 2016 Oct;41(10):2549-2558
pubmed: 27241194
Cochrane Database Syst Rev. 2016 Dec 01;12:CD011958
pubmed: 27905672
Phytother Res. 2018 Aug;32(8):1521-1529
pubmed: 29672953
Evid Based Complement Alternat Med. 2013;2013:363076
pubmed: 23573125
Evid Based Complement Alternat Med. 2018 Jan 29;2018:3017571
pubmed: 29619068
Int Arch Allergy Immunol. 2004 Feb;133(2):113-20
pubmed: 14739579
Mol Med Rep. 2016 Oct;14(4):3704-10
pubmed: 27600871
Food Chem Toxicol. 2012 Oct;50(10):3498-504
pubmed: 22813871
Int Immunopharmacol. 2017 Aug;49:38-49
pubmed: 28550733
Environ Toxicol Pharmacol. 2015 Jul;40(1):230-40
pubmed: 26164594
J Pharm Biomed Anal. 2018 Feb 20;150:377-385
pubmed: 29287265
Acta Pharmacol Sin. 2009 May;30(5):567-75
pubmed: 19363516
Int J Biol Macromol. 2018 Dec;120(Pt A):683-692
pubmed: 30170064
Sci Rep. 2016 Feb 01;6:20246
pubmed: 26832453
Lancet. 2005 Mar 26-Apr 1;365(9465):1147-52
pubmed: 15794969
Arch Pharm Res. 2002 Aug;25(4):433-7
pubmed: 12214850
Environ Toxicol Pharmacol. 2017 Jun;52:99-113
pubmed: 28410469
J Ethnopharmacol. 2011 Oct 31;138(1):40-6
pubmed: 21875661
J Integr Med. 2017 Sep;15(5):365-372
pubmed: 28844213
J Ethnopharmacol. 2015 Apr 22;164:328-33
pubmed: 25701752
Biotechnol Adv. 2018 Nov 1;36(6):1730-1737
pubmed: 29305894
Korean J Physiol Pharmacol. 2010 Jun;14(3):133-7
pubmed: 20631884
Int J Biol Macromol. 2014 Apr;65:441-5
pubmed: 24530338
J Environ Pathol Toxicol Oncol. 2019;38(1):41-50
pubmed: 30806289
J Enzyme Inhib Med Chem. 2009 Oct;24(5):1188-93
pubmed: 19772491
Eur J Pharm Sci. 2018 Sep 15;122:214-229
pubmed: 29966737
Eur J Nutr. 2017 Jun;56(4):1609-1620
pubmed: 27021766
Planta Med. 2000 Apr;66(3):221-7
pubmed: 10821046
J Neurochem. 2010 Dec;115(6):1668-80
pubmed: 20969575
Int J Immunopharmacol. 1996 Jan;18(1):37-44
pubmed: 8732431
Artif Cells Nanomed Biotechnol. 2017 Mar;45(2):372-379
pubmed: 27023851
Int J Mol Sci. 2019 Jan 28;20(3):
pubmed: 30696024
Microb Cell. 2018 Sep 19;5(11):472-481
pubmed: 30483519
J Agric Food Chem. 2012 Feb 22;60(7):1673-81
pubmed: 22188242
J Cell Biochem. 2019 Apr;120(4):5018-5023
pubmed: 30417412
Microb Pathog. 2019 Jan;126:231-238
pubmed: 30439400
J Pharm Pharmacol. 2003 Sep;55(9):1275-82
pubmed: 14604471
Biomed Chromatogr. 2018 Feb;32(2):
pubmed: 28702943
Bull World Health Organ. 2008 May;86(5):408-16
pubmed: 18545744
Eur J Pharmacol. 2015 Oct 15;765:94-9
pubmed: 26297303
Immunopharmacol Immunotoxicol. 2012 Jun;34(3):379-84
pubmed: 21981079
Int J Mol Med. 2014 Dec;34(6):1529-36
pubmed: 25270395
Nat Prod Res. 2019 May;33(10):1486-1490
pubmed: 29271255
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Jul;26(7):493-7
pubmed: 25027428
Vaccine. 2009 Mar 26;27(15):2094-8
pubmed: 19356611
Exp Ther Med. 2018 Sep;16(3):2369-2374
pubmed: 30210589
J Chromatogr A. 2019 May 10;1592:55-63
pubmed: 30691730
Biotechnol Lett. 2004 Jul;26(14):1125-30
pubmed: 15266117
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S611-S620
pubmed: 30444132
Zhongguo Zhong Yao Za Zhi. 2008 Feb;33(3):281-3
pubmed: 18536466
J Pharm Biomed Anal. 2017 Feb 5;134:60-70
pubmed: 27875789
Mol Biol Rep. 2012 Oct;39(10):9285-90
pubmed: 22777209
Pediatr Pulmonol. 2019 Mar;54(3):297-302
pubmed: 30614212
Free Radic Res. 2018 Apr;52(4):480-490
pubmed: 29502482
Int J Biol Macromol. 2013 Feb;53:93-100
pubmed: 23164755
J Agric Food Chem. 2017 Dec 6;65(48):10406-10423
pubmed: 29155570
Biomed Pharmacother. 2019 Mar;111:733-739
pubmed: 30611998
J AOAC Int. 2013 Jan-Feb;96(1):155-60
pubmed: 23513971
Nat Prod Res. 2019 Jan 19;:1-5
pubmed: 30663386
Front Cell Infect Microbiol. 2018 Aug 28;8:299
pubmed: 30211127
Food Funct. 2019 Feb 20;10(2):903-911
pubmed: 30694283